Cultural Intelligence
HAVE YOU EVER WONDERED why we select candidates for Medical Representative positions largely on their personality and potential ability to develop relationships with customers...
First Line Management Development
Getting your first line management role can be quite a challenge. Most first line managers will have spent several years being developed for...
Group Therapy for the Uninitiated
The selling process is changing; an increasing number of customer contacts are now being made in group situations. However, many sales people are concerned...
Better Brains!
Most people in life never actively and deliberately use their brains. Sounds a strange statement to make but...
Compliance? Who Cares…..?
Are regulations negotiable?Who are the MHRA? Currently these are issues for all of us working in the pharma and...
New GP GMS contract – How to help practices increase quality and income
Paul Midgley of the Healthcare Partnership looks at the new GP GMS contract and examines how a ‘yes’ vote will help medical representativeswork more...
Tenders and Proposals
Preparing proposals is enough to make most people cringe. They take far too long to prepare, they’re absolutely boring...
Presenting With Magic
In part three of our series on Presentation Skills we will be looking at ways to communicate and...
PCTs – Mission impossible for 2003?
SO WHAT IS IT that will be keeping PCTs, their Chief Executive’s and other members of the team awake at nights? This table gives...
Breathing in, and Breathing out: Pulmonary Drug Delivery Technologies
Although Millions of people depend on injectable medications for treatment of various ailments, none of them enjoy this experience. The pain, trauma and anguish...
Latest articles
NHSX: Combining the best talent from government, the NHS and industry.
A new joint unit, NHSX, will be created to bring the benefits of modern technology to every patient and clinician. It will combine the...
Sygnature Discovery makes key appointments
Sygnature Discovery has made two key appointments, Dr Allan Jordan and Ms Louisa Jordison. Ms Jordison joins the independent integrated drug discovery and pre-clinical services...
KEYTRUDA results published for advanced renal cell carcinoma
MSD has announced presentation of the full results from the pivotal Phase 3 KEYNOTE-426 trial investigating KEYTRUDA, MSD’s anti-PD-1 therapy, in combination with Inlyta...